DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Bacterial Overgrowth Associated With Chronic Multisymptom Illness Complex

Information source: New Mexico VA Healthcare System
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Gulf War Syndrome

Intervention: Lactulose Breath Test (Procedure); Rifaximin (Drug); Placebo (Drug)

Phase: Phase 1

Status: Recruiting

Sponsored by: Henry C. Lin, MD

Overall contact:
Natalie R Mills, BS, Phone: 505-265-1711, Ext: 2286, Email: Natalie.Mills@va.gov

Summary

The adverse impact of Gulf War Syndrome (GWS) on the health of veterans and on the resources of the VA Healthcare System underscores the need to resolve its underlying cause. In response, the investigators propose to investigate the central hypothesis that gut bacteria may be responsible for symptoms associated with GWS. The investigators will enroll a total of 120 patients with GWS and 90 healthy controls.

Clinical Details

Official title: Bacterial Overgrowth Associated With Chronic Multisymptom Illness Complex

Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Primary outcome:

To compare the pattern of bacterial gas excretion in breath among Veterans with Gulf War Syndrome vs. Controls using Lactulose Breath Test

To determine the response to antibiotic treatment in Gulf War Syndrome patients.

Detailed description: The investigator will assess the prevalence and role of abnormal gut microbial fermentation among Veterans with GWS and investigate the efficacy of diagnostic and treatment strategies directed at indigenous gut microbes in the management of GWS.

Eligibility

Minimum age: 21 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Gulf War Veterans meeting the 1994 Centers for Disease Control and Prevention (CDC)

criteria for the diagnosis of Chronic Fatigue Syndrome(CFS), i. e > six months of one or more symptoms from at least two of the following three clusters: general fatigue, mood and cognitive abnormalities, and musculoskeletal pain

- Must be under the care of a primary physician and have had a previous diagnosis of

Gulf War-related illness or GWS and have medical records documenting investigations to rule out other causes of fatigue

- Minimum of the following laboratory screening tests: complete blood count with

leukocyte differential, erythrocyte sedimentation rate, serum electrolytes, calcium, glucose, blood urea nitrogen, creatinine,urinalysis, and thyroid function tests

- Subjects must also have a GI consult first as part of routine care to confirm

eligibility and availability

- Patients with Irritable Bowel Syndrome (IBS), fibromyalgia (FM), anxiety or

depression will not be excluded, but will be identified for subgroup analysis

- Healthy controls will be screened with complete blood count (CBC) and comprehensive

metabolic panel to confirm eligibility Exclusion Criteria:

- History of peptic ulcer, inflammatory bowel disease, diabetes, cirrhosis, rheumatoid

arthritis, lupus, narcotic dependence,celiac disease, tropical sprue, bowel resection(including gastric, small bowel or colon; but gallbladder surgery or appendectomy are NOT exclusion criteria)

- Patients with chronic illness (HIV, tuberculosis)

- Pregnant or breast-feeding, psychotic depression, bipolar disorder, schizophrenia,

eating disorders

- Healthy subjects will be excluded if their questionnaire indicated abnormal symptom

profile

Locations and Contacts

Natalie R Mills, BS, Phone: 505-265-1711, Ext: 2286, Email: Natalie.Mills@va.gov

New Mexico VA Healthcare System, Albuquerque, New Mexico 87108, United States; Recruiting
Natalie R Mills, BS, Phone: 505-265-1711, Ext: 2286, Email: Natalie.Mills@va.gov
Henry C Lin, MD, Phone: 505-265-1711, Ext: 4511, Email: helin@salud.unm.edu
Henry C Lin, MD, Principal Investigator
Additional Information

Starting date: April 2009
Last updated: April 30, 2013

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017